Press Releases

Washington, D.C. – Following the passage of a bipartisan government funding bill that includes key health care affordability measures—including reforms to pharmacy benefit managers—National Association of Manufacturers President and CEO Jay Timmons issued the following statement:

“Rising health care costs continue to be one of the top challenges facing manufacturers, especially small and medium-sized manufacturers. The NAM has long championed efforts to rein in PBMs, underregulated middlemen who drive up costs by dictating what Americans pay at the pharmacy counter. The reforms adopted by Congress today are an important step toward delivering long-overdue transparency and accountability to these powerful actors.

“As Congress and the Trump administration rightly continue to focus on health care affordability, biopharmaceutical manufacturers are already working to bring down costs and keep lifesaving health care accessible for Americans, including through direct-to-patient platforms that offer lower cost medications to patients who need them. Combined with the reforms to telehealth and expansion of the use of health savings accounts included in H.R. 1, lawmakers are demonstrating their commitment to lowering the cost of health care in the U.S.”

-NAM-

The National Association of Manufacturers is the largest manufacturing association in the United States, representing small and large manufacturers in every industrial sector and in all 50 states. Manufacturing employs nearly 13 million men and women, contributes $2.90 trillion to the U.S. economy annually and accounts for 53% of private-sector research and development. The NAM is the powerful voice of the manufacturing community and the leading advocate for a policy agenda that helps manufacturers compete in the global economy and create jobs across the United States. For more information about the NAM or to follow us on Twitter and Facebook, please visit www.nam.org.

 733 10th St. NW, Suite 700 • Washington, DC 20001 • (202) 637-3000